UA117506C2 - Фармацевтичний препарат, який містить сполуку піридиламінооцтової кислоти - Google Patents
Фармацевтичний препарат, який містить сполуку піридиламінооцтової кислотиInfo
- Publication number
- UA117506C2 UA117506C2 UAA201607988A UAA201607988A UA117506C2 UA 117506 C2 UA117506 C2 UA 117506C2 UA A201607988 A UAA201607988 A UA A201607988A UA A201607988 A UAA201607988 A UA A201607988A UA 117506 C2 UA117506 C2 UA 117506C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pharmaceutical preparation
- acetic acid
- intraocular pressure
- lowering
- acid compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Задачею цього винаходу є встановлення, якій сполуці з-посеред величезної кількості сполук піридиламінооцтової кислоти явно властиве значне зниження внутрішньоочного тиску, і яка може бути використана як засіб для зниження внутрішньоочного тиску або як терапевтичний або профілактичний засіб при глаукомі або очній гіпертензії, і встановлення способу введення і/або дози, при якій запропоновані сполуки зумовлюватимуть стійкий терапевтичний або профілактичний ефект при введенні пацієнтам (головним чином, людям). Запропонований фармацевтичний препарат для зниження внутрішньоочного тиску або для профілактики або лікування глаукоми або очної гіпертензії, де згаданий фармацевтичний препарат містить 0,0003-0,01 % (у відношенні маси до об'єму) (6-{[4-(піразол-1-іл)бензил]-(піридин-3-ілсульфоніл)амінометил}піридин-2-іламіно)-ізопропілацетату або його солі.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461925882P | 2014-01-10 | 2014-01-10 | |
PCT/JP2015/050366 WO2015105144A1 (ja) | 2014-01-10 | 2015-01-08 | ピリジルアミノ酢酸化合物を含む医薬製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA117506C2 true UA117506C2 (uk) | 2018-08-10 |
Family
ID=53520400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201607988A UA117506C2 (uk) | 2014-01-10 | 2015-01-08 | Фармацевтичний препарат, який містить сполуку піридиламінооцтової кислоти |
Country Status (26)
Country | Link |
---|---|
US (8) | US9415038B2 (uk) |
EP (3) | EP3093018B1 (uk) |
JP (6) | JP5846338B2 (uk) |
KR (1) | KR101824829B1 (uk) |
CN (2) | CN105899209B (uk) |
AU (1) | AU2015205188B2 (uk) |
BR (1) | BR112016015763B8 (uk) |
CA (1) | CA2936026C (uk) |
CL (1) | CL2016001756A1 (uk) |
DK (1) | DK3093018T3 (uk) |
EA (1) | EA031734B1 (uk) |
ES (2) | ES2711091T3 (uk) |
GE (1) | GEP20186917B (uk) |
HK (1) | HK1223036A1 (uk) |
HU (1) | HUE041653T2 (uk) |
IL (1) | IL246447B (uk) |
MX (1) | MX370361B (uk) |
MY (1) | MY163235A (uk) |
PH (1) | PH12016501357A1 (uk) |
PL (1) | PL3093018T3 (uk) |
PT (1) | PT3093018T (uk) |
SG (1) | SG11201605653RA (uk) |
TR (1) | TR201902019T4 (uk) |
TW (1) | TWI598113B (uk) |
UA (1) | UA117506C2 (uk) |
WO (1) | WO2015105144A1 (uk) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2935055C (en) * | 2014-01-10 | 2021-08-24 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition containing pyridylaminoacetic acid compound |
ES2711091T3 (es) * | 2014-01-10 | 2019-04-30 | Santen Pharmaceutical Co Ltd | Preparación farmacéutica que contiene compuesto de ácido piridilaminoacético |
KR20240096869A (ko) * | 2014-01-10 | 2024-06-26 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물 |
CN107106570B (zh) * | 2014-12-12 | 2021-02-05 | 兴和株式会社 | 水性组合物 |
AR105215A1 (es) * | 2015-07-01 | 2017-09-13 | Santen Pharmaceutical Co Ltd | Formulación de depósito que contiene ésteres de ácido cítrico |
JP7032134B2 (ja) | 2015-07-09 | 2022-03-08 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含有する予防及び/又は治療剤 |
EP3639855A4 (en) | 2017-06-16 | 2021-03-17 | The Doshisha | COMPOUNDS HAVING CASPASE INHIBITORING ACTIVITY, PHARMACEUTICAL AGENT CONTAINING THEM FOR THE TREATMENT OR PREVENTION OF SYMPTOMS, DISORDERS OR DISEASES OF CORNEAL ENDOTHELIUM, AND APPLICATION OF SUCH PHARMACEUTICAL AGENT |
KR102619458B1 (ko) | 2017-06-16 | 2023-12-29 | 학교법인 도시샤 | mTOR 인히비터를 포함하는, 눈의 증상, 장해 또는 질환을 치료 또는 예방하기 위한 의약 및 그 응용 |
JP7250685B2 (ja) * | 2017-09-29 | 2023-04-03 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含有する医薬 |
CA3086445A1 (en) | 2017-12-21 | 2019-06-27 | Santen Pharmaceutical Co., Ltd. | Omidenepag combination |
CA3087019A1 (en) * | 2017-12-28 | 2019-07-04 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical preparation containing pyridyl aminoacetic acid compound |
CA3162141A1 (en) | 2018-04-24 | 2019-10-31 | Allergan, Inc. | Presbyopia treatments |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002356420A (ja) * | 2001-03-27 | 2002-12-13 | Santen Pharmaceut Co Ltd | 安定な水性液剤 |
KR101609001B1 (ko) * | 2008-03-12 | 2016-04-04 | 우베 고산 가부시키가이샤 | 피리딜아미노아세트산 화합물 |
CN102448940B (zh) * | 2009-03-30 | 2015-10-21 | 宇部兴产株式会社 | 用于青光眼的治疗或预防的医药组合物 |
JP2011057633A (ja) * | 2009-09-11 | 2011-03-24 | Ube Industries Ltd | ピリジルアミノ酢酸化合物を含有する医薬 |
US20120202863A1 (en) * | 2011-02-03 | 2012-08-09 | Gerald Horn | Compositions and methods for treatment of glaucoma |
US9339496B2 (en) | 2012-07-13 | 2016-05-17 | Santen Pharmaceutical Co., Ltd. | Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist |
JP6193655B2 (ja) * | 2012-07-13 | 2017-09-06 | 参天製薬株式会社 | スルホンアミド化合物の組み合わせ |
JP2014019650A (ja) * | 2012-07-13 | 2014-02-03 | Santen Pharmaceut Co Ltd | スルホンアミド化合物とタフルプロストの組み合わせ |
US20140018350A1 (en) | 2012-07-13 | 2014-01-16 | Asahi Glass Co., Ltd. | Combination of sulfonamide compound and tafluprost |
CA2935055C (en) * | 2014-01-10 | 2021-08-24 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition containing pyridylaminoacetic acid compound |
ES2711091T3 (es) | 2014-01-10 | 2019-04-30 | Santen Pharmaceutical Co Ltd | Preparación farmacéutica que contiene compuesto de ácido piridilaminoacético |
KR20240096869A (ko) | 2014-01-10 | 2024-06-26 | 산텐 세이야꾸 가부시키가이샤 | 피리딜아미노아세트산 화합물과 폴리옥시에틸렌 피마자유를 함유하는 의약 조성물 |
-
2015
- 2015-01-08 ES ES15735133T patent/ES2711091T3/es active Active
- 2015-01-08 MY MYPI2016001271A patent/MY163235A/en unknown
- 2015-01-08 CA CA2936026A patent/CA2936026C/en active Active
- 2015-01-08 TR TR2019/02019T patent/TR201902019T4/tr unknown
- 2015-01-08 GE GEAP201514239A patent/GEP20186917B/en unknown
- 2015-01-08 KR KR1020167018735A patent/KR101824829B1/ko active IP Right Grant
- 2015-01-08 BR BR112016015763A patent/BR112016015763B8/pt active IP Right Grant
- 2015-01-08 WO PCT/JP2015/050366 patent/WO2015105144A1/ja active Application Filing
- 2015-01-08 TW TW104100502A patent/TWI598113B/zh active
- 2015-01-08 EP EP15735133.9A patent/EP3093018B1/en active Active
- 2015-01-08 EP EP18190494.7A patent/EP3424503B1/en active Active
- 2015-01-08 HU HUE15735133A patent/HUE041653T2/hu unknown
- 2015-01-08 US US14/592,167 patent/US9415038B2/en active Active
- 2015-01-08 DK DK15735133.9T patent/DK3093018T3/en active
- 2015-01-08 EA EA201691402A patent/EA031734B1/ru unknown
- 2015-01-08 UA UAA201607988A patent/UA117506C2/uk unknown
- 2015-01-08 JP JP2015527691A patent/JP5846338B2/ja active Active
- 2015-01-08 MX MX2016009063A patent/MX370361B/es active IP Right Grant
- 2015-01-08 SG SG11201605653RA patent/SG11201605653RA/en unknown
- 2015-01-08 CN CN201580003994.5A patent/CN105899209B/zh active Active
- 2015-01-08 ES ES18190494T patent/ES2834334T3/es active Active
- 2015-01-08 EP EP20183949.5A patent/EP3750541A1/en not_active Withdrawn
- 2015-01-08 AU AU2015205188A patent/AU2015205188B2/en active Active
- 2015-01-08 PL PL15735133T patent/PL3093018T3/pl unknown
- 2015-01-08 PT PT15735133T patent/PT3093018T/pt unknown
- 2015-01-08 CN CN201811020654.5A patent/CN108743587B/zh active Active
- 2015-11-09 JP JP2015219845A patent/JP6491588B2/ja active Active
-
2016
- 2016-06-26 IL IL246447A patent/IL246447B/en active IP Right Grant
- 2016-07-08 PH PH12016501357A patent/PH12016501357A1/en unknown
- 2016-07-08 CL CL2016001756A patent/CL2016001756A1/es unknown
- 2016-07-18 US US15/212,592 patent/US9943510B2/en not_active Ceased
- 2016-09-29 HK HK16111395.0A patent/HK1223036A1/zh unknown
-
2018
- 2018-02-13 US US15/895,100 patent/US10179127B2/en active Active
- 2018-08-28 US US16/114,721 patent/USRE48183E1/en active Active
- 2018-12-06 US US16/211,839 patent/US10702511B2/en active Active
-
2019
- 2019-03-01 JP JP2019037654A patent/JP6785330B2/ja active Active
-
2020
- 2020-05-29 US US16/887,108 patent/US11197849B2/en active Active
- 2020-10-26 JP JP2020178844A patent/JP7087040B2/ja active Active
-
2021
- 2021-11-08 US US17/521,031 patent/US11793798B2/en active Active
-
2022
- 2022-06-08 JP JP2022092999A patent/JP7402922B2/ja active Active
-
2023
- 2023-09-11 US US18/464,646 patent/US20240000763A1/en active Pending
- 2023-12-11 JP JP2023208468A patent/JP2024019479A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501357A1 (en) | Pharmaceutical preparation containing pyridylamino acetic acid compound | |
PH12018500212A1 (en) | 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
WO2016134223A3 (en) | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof | |
NZ739211A (en) | 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same | |
MX2019012884A (es) | Terapia de combinacion. | |
MX2016010519A (es) | Moleculas para administracion a celulas cancerosas mutantes ros1. | |
JP2016027060A5 (uk) | ||
CA2883751A1 (en) | Methods of treating alzheimer's disease and pharmaceutical compositions thereof | |
WO2017083304A8 (en) | Therapeutic compositions for treatment of human immunodeficiency virus | |
PH12015502406A1 (en) | Orally administrable pharmaceutical composition for prevention or treatment of dry eye syndrome, comprising rebamipide or prodrug thereof | |
MX2021014372A (es) | Compuestos derivados de 1,3,4-oxadiazol como inhibidores de histona desacetilasa 6, y la composicion farmaceutica que comprende los mismos. | |
MX2022005985A (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo. | |
AU2018282104A1 (en) | Use of vibegron to treat overactive bladder | |
WO2018005801A3 (en) | Novel non-systemic tgr5 agonists | |
PH12019502510A1 (en) | Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof | |
MX2019007213A (es) | Derivado de azaciclobutil triazol del grupo anular condensado, metodo de preparacion del mismo y uso del mismo en medicina. | |
MX2018011592A (es) | Compuesto que tiene actividad inhibitoria de idh mutante, metodo de preparacion y usos del mismo. | |
MX2019006942A (es) | Agonistas de receptores de oxitocina no peptidicos. | |
MX2023011203A (es) | Derivado de cumarina para terapia o profilaxis de un trastorno proliferativo celular. | |
PH12020500436A1 (en) | Aromatic derivative, preparation method for same, and medical applications thereof | |
WO2016122288A3 (ko) | 베르베논 유도체 및 재관류 치료제를 포함하는 뇌혈관 질환, 동맥경화증 또는 심혈관 질환 치료 또는 예방용 병용 제제 | |
NZ708511A (en) | Methods for controlling blood pressure and reducing dyspnea in heart failure | |
MX2019007360A (es) | Derivado de triazol azabiciclo-sustituido, preparacion, metodo del mismo, y aplicacion de la misma en medicina. | |
EP4338751A3 (en) | Medicament comprising combination of sepetaprost and rho-associated coiled-coil containing protein kinase inhibitor | |
EA201690903A1 (ru) | Лечение глаукомы с использованием лаквинимода |